Biotechnology

Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients with recurrent, persistent or metastatic cervical cancer, according to late breaking results from the KEYNOTE-826 study presented at the ESMO Congress 2021. (1)  Credit: ESMO Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight...

Over 800 million people around the world don't have enough to eat. Tragically, that number has only increased amid COVID-19, likely foreshadowing a perilous course ahead as we confront another, equally grave crisis.According to...

COLUMBIA, Mo. – While assessing a pregnant woman with premature labor in 1983, Linda Bullock noticed bruises on the woman. When she asked what happened, the woman told Bullock a refrigerator had fallen on...

With the children of the company’s co-founders right up front, the Ginkgo Bioworks team rang the bell of the New York Stock Exchange this morning, taking the synthetic biology company public. The synthetic biology...

REGISTER NOW Broadcast Date: October 5, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET We are all keenly aware that viruses can negatively impact our lives, but what about viruses that shape our existence...

Broadcast Date: October 13, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW Do you currently chug along check boxing regulatory mandates described by USP? If so, you may be putting patients,...

India won’t just be the pharmacy of the world but also the research lab of the world, and the bio-strategy document that is in place will lead India to become a $150 billion market...

Kimitec, a company dedicated to researching, developing, and commercializing biopesticides, prebiotic biostimulants, and probiotics, has invested 50 million euros in expanding its plant in the Almeria town of Vicar, which will become the largest...

Eighteen months into the covid-19 pandemic, with the delta variant fueling a massive resurgence of disease, many hospitals are hitting a heartbreaking new low. They're now losing babies to the coronavirus. The first reported...

GammaDelta Therapeutics Ltd. (GDT), a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer, today announced that it has initiated a first-in-human Phase I clinical trial evaluating...